US drugs giant Pfizer posts a drop in sales in a post-Covid vaccine slump | This is Money

Retrieved on: 2024-05-02 16:45:39

Tags for this article:

COVID-19 vaccination in the United States

Pfizer

Research and development in the United States

COVID-19 vaccine

Albert Bourla

Investment fund

Click the tags to see associated articles and topics

US drugs giant Pfizer posts a drop in sales in a post-Covid vaccine slump | This is Money. View article details on hiswai:

Summary

The article discusses Pfizer's revenue decline in early 2024 due to lower COVID vaccine sales, despite an overall business confidence and shift towards cancer treatments. The tags highlight the context of COVID-19 vaccination and pharmaceutical development in the U.S.

Article found on: www.thisismoney.co.uk

View Original Article